Sintx Technologies (SINT) Competitors $1.75 +0.02 (+1.16%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.85 +0.10 (+5.66%) As of 04/17/2025 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SINT vs. NEPH, RVP, NXGL, XAIR, QTI, VVOS, LFWD, PETV, IRIX, and NMTCShould you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include Nephros (NEPH), Retractable Technologies (RVP), NEXGEL (NXGL), Beyond Air (XAIR), QT Imaging (QTI), Vivos Therapeutics (VVOS), ReWalk Robotics (LFWD), PetVivo (PETV), IRIDEX (IRIX), and NeuroOne Medical Technologies (NMTC). These companies are all part of the "medical equipment" industry. Sintx Technologies vs. Nephros Retractable Technologies NEXGEL Beyond Air QT Imaging Vivos Therapeutics ReWalk Robotics PetVivo IRIDEX NeuroOne Medical Technologies Sintx Technologies (NASDAQ:SINT) and Nephros (NASDAQ:NEPH) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings. Which has higher earnings and valuation, SINT or NEPH? Nephros has higher revenue and earnings than Sintx Technologies. Nephros is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSintx Technologies$1.25M3.53-$8.26M-$50.56-0.03Nephros$14.16M1.47-$1.58M-$0.09-21.77 Which has more risk and volatility, SINT or NEPH? Sintx Technologies has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, Nephros has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500. Do institutionals and insiders hold more shares of SINT or NEPH? 18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 41.1% of Nephros shares are held by institutional investors. 0.0% of Sintx Technologies shares are held by company insiders. Comparatively, 4.1% of Nephros shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer SINT or NEPH? Nephros has a consensus target price of $5.00, indicating a potential upside of 155.23%. Given Nephros' stronger consensus rating and higher possible upside, analysts clearly believe Nephros is more favorable than Sintx Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sintx Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nephros 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to SINT or NEPH? In the previous week, Sintx Technologies had 1 more articles in the media than Nephros. MarketBeat recorded 1 mentions for Sintx Technologies and 0 mentions for Nephros. Nephros' average media sentiment score of 0.00 beat Sintx Technologies' score of -1.00 indicating that Nephros is being referred to more favorably in the news media. Company Overall Sentiment Sintx Technologies Negative Nephros Neutral Is SINT or NEPH more profitable? Nephros has a net margin of -6.86% compared to Sintx Technologies' net margin of -358.79%. Nephros' return on equity of -11.39% beat Sintx Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Sintx Technologies-358.79% -140.68% -78.29% Nephros -6.86%-11.39%-8.30% Does the MarketBeat Community believe in SINT or NEPH? Sintx Technologies received 23 more outperform votes than Nephros when rated by MarketBeat users. Likewise, 61.02% of users gave Sintx Technologies an outperform vote while only 43.33% of users gave Nephros an outperform vote. CompanyUnderperformOutperformSintx TechnologiesOutperform Votes3661.02% Underperform Votes2338.98% NephrosOutperform Votes1343.33% Underperform Votes1756.67% SummaryNephros beats Sintx Technologies on 12 of the 18 factors compared between the two stocks. Get Sintx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SINT vs. The Competition Export to ExcelMetricSintx TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.40M$4.04B$5.30B$7.34BDividend YieldN/A46.44%5.45%4.30%P/E Ratio-0.0327.6821.8617.80Price / Sales3.5347.06380.5497.74Price / CashN/A51.0838.2634.64Price / Book0.015.816.453.98Net Income-$8.26M$67.09M$3.22B$247.81M1 Month Performance-41.47%-11.67%-9.71%-7.84%1 Year Performance-79.07%14.51%11.51%1.60% Sintx Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SINTSintx Technologies0.2251 of 5 stars$1.75+1.2%N/A-78.1%$4.40M$1.25M-0.0340Short Interest ↑Gap DownNEPHNephros1.7241 of 5 stars$1.95-4.4%$5.00+156.4%-1.6%$20.67M$14.16M-21.6730RVPRetractable TechnologiesN/A$0.68flatN/A-33.2%$20.36M$38.27M-1.26240NXGLNEXGEL0.4284 of 5 stars$2.63+2.3%N/A+28.3%$20.13M$8.69M-4.5310Short Interest ↑Gap DownXAIRBeyond Air4.217 of 5 stars$0.24-2.3%$3.67+1,453.0%-79.9%$16.24M$3.02M-0.2270QTIQT ImagingN/A$0.56+1.8%N/A-8.6%$15.20M$4.00M0.00N/APositive NewsGap UpVVOSVivos Therapeutics1.5898 of 5 stars$2.52-1.2%$6.30+150.0%-21.1%$14.84M$14.58M-0.44160Analyst ForecastNews CoverageLFWDReWalk Robotics2.6542 of 5 stars$1.37-6.8%$9.00+556.9%-71.5%$14.56M$25.66M-0.5560Short Interest ↓Positive NewsGap DownPETVPetVivoN/A$0.61flatN/A-22.8%$14.51M$1.05M-1.3620Gap UpIRIXIRIDEX1.3404 of 5 stars$0.85-1.4%$2.00+135.3%-66.2%$14.27M$48.67M-1.27120Analyst ForecastHigh Trading VolumeNMTCNeuroOne Medical Technologies0.2775 of 5 stars$0.43-8.8%N/A-49.1%$13.37M$5.75M-1.6720News CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies NEPH Alternatives RVP Alternatives NXGL Alternatives XAIR Alternatives QTI Alternatives VVOS Alternatives LFWD Alternatives PETV Alternatives IRIX Alternatives NMTC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SINT) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sintx Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sintx Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
